Skip to Main Content

Advertisement

Skip Nav Destination

Tissue-specific gene therapy for prostate cancer by a probasin promoter driven replication-competent retroviral vector

Cancer Res (2005) 65 (9_Supplement): 1253–1254.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal